Dianne Nast Appointed as Interim Co-Lead Counsel in Zytiga Lawsuit

Dianne Nast of NastLaw and Michael Roberts of Roberts Law Group have been appointed as interim co-lead class counsel in a lawsuit against the manufacturers of Zytiga. The case alleges that Janssen, a subsidiary of Johnson & Johnson, willfully and wrongfully maintained monopoly power and harmed competition by initiating and pursuing meritless patent infringement litigation that delayed entry of generic … Read More

Dianne Nast Appointed as Interim Co-Lead Counsel in Insulin Price Fixing Lawsuit

Dianne Nast of NastLaw, Michael Roberts of Roberts Law Group, and Don Barrett of Barrett Law Group, have been appointed as interim co-lead class counsel in a class action lawsuit involving several insulin drugs. The Plaintiffs, direct purchasers of the analog insulin drugs NovoLog, Humalog, Lantus and Levemir, have accused the three insulin drug manufacturers of those drugs – Novo … Read More

Generic Drug Price Antitrust Litigation Expanded in Pennsylvania Court

The Eastern District of Pennsylvania has become the hub for the Generic Drug Price Fixing Antitrust Litigation. On April 7, the U.S. Judicial Panel on Multidistrict Litigation transferred several additional cases to the MDL that is pending in the Eastern District of Pennsylvania Court, expanding the scope of the litigation to include any actions related to the alleged price-fixing of … Read More

Dianne Nast Named Co-Lead Counsel in Major Antitrust Litigation

Dianne Nast, founder of NastLaw, was named as co-lead counsel in the Generic Digoxin and Doxycycline Antitrust Litigation. Roberta Liebenberg of Fine, Kaplan, and Black was appointed as co-lead counsel alongside Ms. Nast. The appointment is being hailed as a major advancement in diversity, as this is one of the only known instances of two women being appointed to lead a … Read More

Dermatologic Drug Prices Rise 400% in Six Years

The recent uproar surrounding the prices of EpiPens has attracted the attention of the media, lawmakers, and lawyers around the country. EpiPen prices have risen over 600 percent in the past several years, for no apparent reason other than to pad the pockets of Mylan Pharmaceuticals. However, Mylan is not the only company that is raising prices on its drugs. … Read More

Dry Max Pampers Litigation – Important Notice from the Court

UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF OHIO WESTERN DIVISION (CINCINNATI) IN RE DRY MAX PAMPERS LITIGATION : CASE NO. 1:10-cv-00301 TSB _________________________________________ TO ALL PERSONS WHO PURCHASED OR ACQUIRED PAMPERS BRAND DIAPERS WITH “DRY MAX” – READ THIS NOTICE CAREFULLY. YOUR LEGAL RIGHTS MAY BE AFFECTED. On June 7, 2011, this Court approved notice of a tentative … Read More

NastLaw Files Antitrust Case Over Alleged Dairy Product Price Fixing

Milk Price Fixing Antitrust

Dianne Nast, of NastLaw, LLC., and other law firms have filed an antitrust case in the Souther District of Illinois alleging that a consortium of farmers conspired to keep the price of milk and other dairy products higher than it should be. The complaint alleges that a Cooperatives Working Together (“CWT”) and its members have engaged in a continuing contract, … Read More